Stockscreener 앱 받기
3.27
2.83%
0.09
시장 영업 전:
3.32
0.05
+1.53%
Quanterix Corp 주식(QTRX)의 최신 뉴스
Quanterix Corporation Launches PhenoCode 2.0 Molecular Barcoding Kit, Confirms TIME And High-Plex ADC Panels For Fourth Quarter Shipment, And Opens Custom ADC Panel Development - marketscreener.com
Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026 - marketscreener.com
Global Alzheimer’s Disease Biomarker Market Poised for Phenomenal Expansion at a Growth Rate of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.
Quanterix Corp (NASDAQ: QTRX) Grants 260,315 Derivative Securities to Chief Commercial Officer Gute James Edward Jr. - Kalkine Media
Quanterix (QTRX) awards its CCO 260K RSUs - Stock Titan
Quanterix CTO Michael Francis Executes 1,558 Stock Options and Forfeits 467 Shares on September 15, 2026 - Kalkine Media
365,326 stock units go to two new employees at Quanterix. They vest over four years. - Stock Titan
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Quanterix (QTRX) CTO converts RSUs, withholds shares for taxes - Stock Titan
Quanterix Corporation Announces Appointment of Dr. Yuri Fesko to Chief Medical Officer - marketscreener.com
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Quanterix (NASDAQ: QTRX) CTO uses shares to cover exercise price or taxes - Stock Titan
Bruker Corporation Executive is Named Finance Chief at Quanterix - Medical Product Outsourcing
Quanterix (QTRX) director adds 3,955 shares via RSU vest - Stock Titan
Quest Diagnostics Executive Recruited to Quanterix’s Senior Management Team - Medical Product Outsourcing
Quanterix (QTRX) CCO files initial ownership report with no shares - Stock Titan
Quanterix (QTRX) director now holds 162,401 shares - Stock Titan
Quanterix (QTRX) Q2 2026 Earnings Call Transcript - The Globe and Mail
QTRX Maintains Rating by Canaccord Genuity -- Price Target Lowered to $3.00 - GuruFocus
Quanterix (NASDAQ:QTRX) Price Target Cut to $3.00 by Analysts at Canaccord Genuity Group - MarketBeat
Canaccord cuts Quanterix stock price target on weak Q2 results - Investing.com
GSA Capital Partners LLP Makes New Investment in Quanterix Corporation $QTRX - MarketBeat
Quanterix Reshapes Sales Strategy, Targets Q4 FDA Decision for Alzheimer’s Blood Test - sharewise.com
Quanterix (NASDAQ:QTRX) Lowered to Sell Rating by Wall Street Zen - MarketBeat
Quanterix Stock Price Forecast. Should You Buy QTRX? - StockInvest.us
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Quanterix Corp (QTRX) director-linked trusts buy 99,400 shares in open market - Stock Titan
Quanterix Corp (QTRX) Stock News Today - TradingKey
Quanterix Corp (QTRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Quanterix at canaccord growth conference: sales reset aims to lift growth - Investing.com
Quanterix (QTRX) Earnings Shake Up The Story As Fair Value Still Sits Higher - Yahoo Finance
QTRX Maintains Hold Rating -- Price Target Lowered to $3.00 by T - GuruFocus
TD Cowen Issues Pessimistic Forecast for Quanterix (NASDAQ:QTRX) Stock Price - MarketBeat
Quanterix earnings missed by $0.64, revenue fell short of estimates - Investing.com Canada
Quanterix Corp (QTRX) (Q2 2026) Earnings Call Highlights: Revenue Miss and Guidance Cut Amid Market Softness - GuruFocus
Earnings call transcript: Quanterix Q2 2026 revenue miss sends shares down 43% - Investing.com South Africa
Quanterix Corp (QTRX) (Q2 2026) Earnings Call Highlights: Revenue Miss and Guidance Cut Amid ... - Yahoo Finance
Quanterix (NASDAQ:QTRX) Drops 39% After Outlook Revision Pushes Breakeven Back to 2027 - TechStock²
Quanterix Q2 Earnings Call Highlights - MarketBeat
Quanterix Cuts 2026 Revenue Outlook as Commercial Challenges Delay Cash-Flow Break-Even - Yahoo Finance
Quanterix Q2 2026 slides: revenue miss prompts guidance cut - Investing.com
Quanterix Corp (QTRX) Misses Q2 Earnings Estimates with EPS at - GuruFocus
Quanterix appoints Jim Gute as chief commercial officer - Investing.com
QTRX Looks 65.9% Undervalued on GF Value™ Despite Revenue Miss - GuruFocus
Quanterix Q2 adjusted EPS misses estimates, sales rise 34% - scanx.trade
Form 8K Quanterix Corp For: 10 August By Investing.com - Investing.com Nigeria
Quanterix (NASDAQ:QTRX) Announces Quarterly Earnings Results - MarketBeat
Quanterix Corp 2026: Revenue $32.91M, EPS ($1.04) — 10-Q Summary - TradingView
Quanterix (QTRX) boosts revenue as Alzheimer’s bets rise amid big write-downs - Stock Titan
Quanterix Corporation Provides Financial Guidance for the Third Quarter of 2026 - marketscreener.com
Form 8K Quanterix Corp For: 10 August - Investing.com India
Quanterix Q2 2026 earnings: Revenue rises 34% as outlook is cut - TradingKey
Quanterix Q2 revenue rises to $32.9 million as 2026 outlook cut - Quiver Quantitative
Quanterix Corporation Announces Appointment of Jim Gute as Chief Commercial Officer - marketscreener.com
Quanterix Releases Financial Results for the Second Quarter of 2026 - Yahoo Finance
Earnings To Watch: Quanterix Corp (QTRX) Q2 2026 -- GF Value Sees 253% Upside - GuruFocus
QUANTERIX Q2 2026 Earnings Preview: Recent $QTRX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
1.51%
0.97%
자본화:
|
볼륨(24시간):